ASH2L


Summary:

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in ASH2L


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF IPI GO:0005515 protein binding
MF IDA GO:0008013 beta-catenin binding
MF TAS GO:0018024 histone-lysine N-methyltransferase activity
MF IBA GO:0042800 histone methyltransferase activity (H3-K4 specific)
MF IDA GO:0042800 histone methyltransferase activity (H3-K4 specific)
MF IBA GO:0044212 transcription regulatory region DNA binding
Showing 1 to 6 of 31 rows rows per page

Gene expression in normal tissue: ASH2L

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

undefined5Chromatin histone acetylation1

Pathways in ASH2L


Loading, please wait...
Database
Pathway ID
Pathway Des.
wikipathways WP2004 miR-targeted genes in lymphocytes - TarBase
wikipathways WP2005 miR-targeted genes in muscle cell - TarBase
kegg hsa04934 Cushing,s syndrome - Homo sapiens (human)
reactome R-HSA-1266738 Developmental Biology
reactome R-HSA-162582 Signal Transduction
reactome R-HSA-195721 Signaling by WNT
Showing 1 to 6 of 19 rows rows per page

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD60 Quinoclamine 3
iGMDRD289 Parthenolide 1
iGMDRD105 Triptolide 3
iGMDRD150 RITA 3
Showing 1 to 4 of 6 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in ASH2L

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​